Ana səhifə

Supplementary material


Yüklə 416 Kb.
tarix24.06.2016
ölçüsü416 Kb.
SUPPLEMENTARY MATERIAL
Lycopus europaeus: Phenolic fingerprint, antioxidant activity and antimicrobial effect on clinical Staphylococcus aureus strains
Silvia Fialováa,*, Lívia Slobodníkováb, Lucia Veizerovác and Daniel Grančaia
1Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovak Republic;

bInstitute of Microbiology, Faculty of Medicine, Comenius University and University Hospital in Bratislava, 811 08 Bratislava, Slovak Republic;

cDepartment of Pharmaceutical Analysis and Nuclear Pharmacy; Toxicological and Antidoping center, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovak Republic.
*Corresponding author. E-mail: fialova@fpharm.uniba.sk
Abstract

Lycopus europaeus L. leaves water extract (LEL) was submitted to phytochemical analysis, and evaluated for its antibacterial and antioxidant effects. Antibacterial activity testing was performed on Staphylococcus aureus clinical strains from catheter-related and skin infections by broth microdilution test. LEL showed bactericidal activity at concentrations from 2500 to 5000 μg/mL against all, including methicillin resistant and polyresistant nosocomial strains. Antioxidant activity was examined using DPPH and ABTS (11.3 and 9.8 μg/ml resp.) and by FRAP method (891μmol AAE/g dry extract). Phytochemical analysis of LEL was performed by LC-DAD-MS/MS. Ten phenolic compounds were identified; two minor compounds (glucopyranosyl rosmarinic acid and sagerinig acid) have not been described in Lycopus yet. The major compounds, considered to be responsible for biological activities detected in the study, were determined as rosmarinic acid (76 mg/g) and luteolin-7-O-glucuronide (23 mg/g). L. europaeus arises from our study as a promising source of antibacterial agents for topical usage.
Keywords: Lycopus; phenolics; antioxidant; antimicrobial;

Experimental


Plant Material

Aerial parts of Lycopus europaeus were collected from The Garden of Medical Plants, Faculty of Pharmacy in Bratislava. Harvested plant was 2 years old and was collected at the flowering time. The leaves were separated from the stems and flowers and dried at 32 – 35 °C. A voucher specimen (LE11ZLR) has been deposited at the Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia.



Extraction

Water extract of dried leaves of L. europaeus was prepared according to Pharmacopoea Bohemoslovaca 4th edition (1987). The infusion was lyophilised; the yield was 10.40 %.



General Experimental Procedures

Disk-diffusion method on Mueller-Hinton agar medium (OXOID, Great Britain) was used for detection of antimicrobial susceptibility of S. aureus strains to oxacillin, gentamicin, ciprofloxacin, vancomycin, cotrimoxazole, erythromycin and clindamycin, using commercial antibiotic disks (OXOID, Great Britain; CLSI 2009a). The susceptibility test results were interpreted according to the CLSI guidelines (CLSI 2010). Resistance to methicillin/oxacillin was confirmed by Penicillin Binding Protein 2a latex agglutination test (OXOID, Great Britain).

The minimal inhibitory (MIC) and minimal bactericidal concentrations (MBC) of LEL were tested by broth microdilution assay according to the CLSI (CLSI 2009b). LEL for antimicrobial activity testing was dissolved in sterile aqua pro injectione and filtration-sterilized. Serial geometric dilutions from 5000 to 156 µg.mL-1 were prepared in the Mueller-Hinton Broth (OXOID, Great Britain). All tests were performed in three independent runs.

The LC-MS analyses were performed on an Agilent 1260 Infinity LC System (Agilent Technologies, Germany), equipped with a binary pump, an autosampler, a column thermostat, and a diode array detector (DAD), coupled to a quadrupole-time of flight (6520 Accurate-Mass QTOF) instrument equipped with an orthogonal ESI source (Agilent Technologies, Germany). HPLC separation of LEL was carried out on a Hypersil BDS-C18 column (4.0×250mm, 5µm, Agilent Technologies, Germany) at 35°C and a flow rate of 0.4 mL/min. Water (pH 2.8 with HOAc) and MeCN were used as mobile phase A and B respectively. The following gradient program was used: 10% B (20 min), 20% B (25 min), 60% (50 min), 95% (62 min) and 10% (70 min). The ESI ion source parameters were as follows: capillary voltage: 3.5 kV, nebulizer: 40 psi (N2), dry gas flow: 10 L/min (N2), and dry temperature: 300 °C. The mass spectrometer was operated in an autoMS2 mode where each negative ion MS scan (m/z 100-3000, average of 4 spectra) was followed by MS2 scans (m/z 100-3000, average of 4 spectra, isolation window of 4 amu, collision energy 20 eV) of the two most intense precursor ions. Ions were excluded from analyses for 0.5 min after two MS2 spectra had been acquired. Nitrogen was used as collision gas.

The UV wavelengths used for determining the phenolic compounds were 280 nm for flavonoids and 320 nm for phenolic acids. Phenolic compounds were identified by comparing their UV and mass spectra with literature and authentic standards when available and by measuring accurate m/z. The quantitative determination of LEL components was provided by the method of external standards. We used luteolin-7-O-glucoside for determination of flavonoids and rosmarinic acid for determination of phenolic acids. Chromatographic standards and standards of free radicals were purchased from Sigma-Aldrich, Germany.
Radical scavenging activities determined by decolorization of 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) were measured spectrophotometrically (Nagy et al. 2006). The sample (200 μL) with 1.8 mL of DPPH solution (55 μmol) was incubated at room temperature for 30 min. The absorbance was read against a blank at 517 nm. The ABTS, 2,2 azinobis (3-ethylbenzothiazoline-6-sulfonic acid) radical cation decolorization assay was carried out, using an improved ABTS decolorization assay of Re et al. (1999). For the study the ABTS•+ solution was diluted with ethanol to an absorbance of 0.70 (± 0.02) at 734 nm and equilibrated at 30 °C. After addition of 2 mL of diluted ABTS solution to 20 μL of sample, the absorbance reading was taken exactly 6 min after initial mixing. Ferric-reducing antioxidant power assay (FRAP) was carried out according to the procedure of Benzie & Strain (1996). Briefly, the FRAP reagent was prepared from acetate buffer 300 mmol/L (pH 3.6), 10 mmol/L TPTZ solution in 40 mmol/L HCl and 20 mmol/L FeCl3 × 6 H2O. The FRAP reagent was prepared fresh daily. Fifty microliters of sample were added to 1.5 mL of the FRAP reagent. The absorbance of the reaction mixture was recorded at 593 nm after 5 min. The standard curve was linear between 100 and 1000 μmol ascorbic acid (AA). Results are expressed as ascorbic acid equivalents (AAE) in μmol AAE/g dry mass. All determinations were performed in triplicate.
Bacterial strains

Thirty-one clinical S. aureus strains and two cultures collection strains (ATCC 29213, and ATCC 43300) were included in the study. The clinical strains were isolated from infections associated with central venous, wound, and respiratory suction catheters, and from skin lesions of patients with atopic dermatitis and impetigo (Table S1). The strains were preserved in Brain-Heart Infusion with 20% glycerol at -20 °C and before the analysis were cultivated overnight at 37 °C on blood agar.


Table S1. Lycopus europaeus water infusion activity on clinical Staphylococcus aureus strains.

Strain

Origin

Antimicrobial susceptibility

LEL MIC

[g.mL-1]

LEL MBC

[g.mL-1]

OXA

GEN

CIP

VAN

COT

ERY

CLI

1

CVC

R

S

R

S

S

R

R

2500

2500

2

CVC

R

S

R

S

S

R

R

2500

2500

3

CVC

S

S

R

S

S

S

S

5000

5000

4

CVC

R

S

R

S

S

R

R

2500

2500

5

CVC

S

S

R

S

S

R

R

2500

2500

6

CVC

R

S

R

S

S

R

R

2500

2500

7

CVC

R

R

R

S

S

R

R

2500

2500

8

CVC

S

S

R

S

S

R

R

2500

2500

9

WDC

S

S

S

S

S

R

R

2500

2500

10

WDC

S

S

S

S

S

S

S

5000

5000

11

WDC

S

S

S

S

S

S

S

5000

5000

12

WDC

S

S

S

S

S

S

S

2500

2500

13

WDC

S

S

S

S

S

S

S

5000

5000

15

RSC

R

S

R

S

R

R

R

2500

2500

16

RSC

R

S

R

S

S

R

R

2500

2500

13

RSC

S

S

S

S

S

R

R

2500

2500

14

ADL

S

S

S

S

S

S

S

2500

5000

15

ADL

S

S

S

S

S

S

S

2500

2500

16

ADL

S

R

R

S

S

S

S

2500

2500

17

ADL

S

S

S

S

S

S

S

5000

5000

18

ADL

S

R

S

S

S

R

R

2500

2500

19

ADL

S

S

S

S

S

R

S

2500

2500

20

ADL

R

S

R

S

S

R

R

2500

2500

21

ADL

S

S

S

S

S

S

S

2500

2500

22

ADL

S

S

S

S

S

R

R

2500

2500

23

ADL

S

S

S

S

S

S

S

2500

2500

24

IMP

S

S

S

S

S

S

S

5000

5000

25

IMP

S

S

S

S

S

S

S

2500

2500

26

IMP

R

S

R

S

S

R

S

2500

5000

27

IMP

R

R

R

S

S

R

S

2500

5000

28

IMP

S

S

S

S

S

R

R

2500

5000

ATCC 43300

R



















2500

2500

ATCC 29213

S



















5000

5000

CVC – central venous catheter; WDR - wound drainage catheter; RSC - respiratory suction catheter; ADL – atopic dermatitis skin lesion; IMP – impetigo; OXA – oxacillin; GEN – gentamicin; CIP – ciprofloxacin; VAN – vancomycin; COT – cotrimoxazole; ERY – erythromycin; CLI – clindamycin; LEL – Lycopus europaeus leaves water infusion; MIC – minimal inhibitory concentration; MBC – minimal bactericidal concentration; S – susceptible; R – resistant
Table S2. Free radicals scavenging activity of L. europaeus leaves water extract and its major containing compound rosmarinic acid, in comparison to standard antioxidant – ascorbic acid.

 

SC50 DPPH (μg.mL-1)a

SC50 ABTS (μg.mL-1)a

LEL water extract

11.27 ± 0.06

9.81 ± 0.32

Rosmarinic acid

1.70 ± 0.07

2.10 ± 0.05

Ascorbic acid

1.65 ± 0.06

1.00 ± 0.02

aValues are presented as means ± standard deviation (n=3)

SC50 - 50% scavenging concentration



Table S3. Flavonoids and caffeic acid derivatives of L. europaeus leaves water extract, their corresponding retention times (TR), molecular ions [M-H] and MS2 fragments in LC-MS analysis and quantitative abundance of polar phenolic compounds (mg.g-1) in L. europaeus water extract.

Compound

TR (min)

[M-H]

MS-MS (20eV)

Mass concentration (mg.g-1)*

1. Protocatechuic aldehyde

16.1

137.0243

108.0214

119.0130


< LOQ

2. Caffeic acid

21.9

179.0357

135.0441

    1. ± 0.10

3. Quercetin-7-O-glucuronide

32.5

477.0689

301.0367

insufficient resolution

4. Lithospermic acid

33.3

537.1058

197.0441

179.0367


161.0247

2,18 ± 0.05

5. Luteolin-7-O-glucuronide

35.2

461.0745

285.0415

23.2 ± 2.14

6. Glucopyranosyl rosmarinic acid

35.9

521.1357

161.0267

359.0787


3.60 ± 0.16

7. Sagerinic acid

36.9

719.1638

359.0791

161.0273


1.95 ± 0.08

8. Luteolin-7-O-glucoside

38.0

447.0954

285.0421

< LOQ

9. Apigenin-7-O-glucuronide

40.1

445.0785

269.0471

1.22 ± 0.06

10. Rosmarinic acid

41.9

359.0789

161.0265

197.0491


179.0363

76.3 ± 4.34

*Values (mg.g-1 dry extract) are presented as means ± standard deviation (n=3), External standards: luteolin-7-O-glucoside (used for flavonoids determination), rosmarinic acid (used for phenolic acids determination), LOQ – limit of quantification




Figure S1. Total Ion Current (TIC) chromatogram of L. europaeus leaves water extract from the ESI-MS in negative mode. 1: protocatechuic aldehyde; 2: caffeic acid; 3: quercetin 7 O glucuronide; 4: lithospermic acid; 5: luteolin-7-O-glucuronide; 6: glucopyranosyl rosmarinic acid; 7: sagerinic acid; 8: luteolin-7-O-glucoside; 9: apigenin-7-O-glucuronide; 10: rosmarinic acid.


Figure S2. LC-ESI-MS2 mass spectra of glucopyranosyl rosmarinic acid in L. europaeus leaves water extract.



Figure S3. LC-ESI-MS2 mass spectra of sagerinic acid in L. europaeus leaves water extract.

References


Benzie, I.F.F. & Strain, J.J. (1996). The Ferric Reducing Ability of Plasma (FRAP) as a

Measure of ‘‘Antioxidant Power’’: The FRAP Assay. Analytical biochemistry, 239, 70-76.

Clinical and Laboratory Standards Institute. (2009a). Performance standards for antimicrobial disk susceptibility tests; Approved standard - Tenth edition. CLSI Document M2-A10.Wayne, Pennsylvania, USA.

Clinical and Laboratory Standards Institute. (2009b). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard – Eight edition. CLSI Document M07-A8. Wayne, Pennsylvania, USA.

Clinical and Laboratory Standards Institute. (2010). Performance standards for antimicrobial susceptibility testing: 20th informational supplement. CLSI Document M100-S20. Wayne, Pennsylvania, USA.

Nagy, M., Spilková, J., Vrchovská, V., Kontšeková, Z., Šeršeň, F., Mučaji, P. & Grančai, D. (2006). Free radical scavenging activity of different extracts and some constituents from the leaves of Ligustrum vulgare and L. delavayanum. Fitoterapia, 77, 395-397.



Pharmacopoea Bohemoslovaca PhBs IV. (1987). Praha: Avicenum.

    Re, R., Pellegrini, N., Proteggente, A., Pannala, A., Yang, M. & Rice-Evans, C. (1999). Antioxidant activity applying an inproved ABTS radical cation decolorization assay. Free Radical Biology & Medicine, 26, 1231-1237.


Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©atelim.com 2016
rəhbərliyinə müraciət